Dechert Advises the Investors in the €4 Million Financing of Mila's Clinical Study
Dechert advised Kurma Partners, BNP Paribas Développement and Bpifrance through its fund Patient Autonomy, in their investment of a total amount of €4 million in Mila, a French company developing digital therapeutic solutions which tap into links between music and children’s cognitive developments.
This financing will allow the company to launch an international clinical study into the benefits of rhythm for children suffering from specific learning and language disorders in order to clinically validate its solution.
The Dechert team advising the investors was led by partner Anne-Charlotte Rivière and included associate Louis Taslé d'Héliand in corporate/M&A as well as national partner Marie Fillon and associate Louis de Chezelles in intellectual property.
About Dechert
Dechert is a leading global law firm with 25 offices around the world. We advise on matters and transactions of the greatest complexity, bringing energy, creativity and efficient management of legal issues to deliver commercial and practical advice for clients.
